Medications are the primary treatment for Parkinson’s.  They help improve movement by supporting the brain’s Dopamine system, which is disrupted in Parkinson’s.

Early in the disease, medication can provide smooth and meaningful symptom relief. Over time, effects may become less predictable, or adjustments may be needed. This does not mean treatment has failed.  It means Parkinson’s is evolving, and your treatment plan can evolve with it.

Parkinson’s medications are often grouped into categories based on how they support dopamine or manage specific symptoms.

• Dopamine Targeting Treatments
• Symptom Targeted Treatments

Each plays a different role in care. We will explore both in more detail below.


Understanding the Strategy Behind the Prescription

Medications The Foundation of PD Treatment

One prescription often opens the door. There is rarely a single perfect dose. Parkinson’s medications evolve as the disease evolves.

Medication decisions aren’t isolated. They reflect your symptoms & daily rhythm. They’re shaped through conversations with you.

Management isn’t one-size-fits-all. It’s refined over time. One prescription opens the door

Medication management is rarely a straight line. It’s refined through response and adjustment. One prescription opens the door.

What Parkinson’s Medications Actually Target

Basic classifcations Of PD meds

Disease-Targeting Medications

Dopamine-targeting medications focus on supporting Dopamine signaling in the brain. They may replace Dopamine, mimic its effects, or help existing Dopamine last longer.

These medications form the foundation of PD treatment and are most effective for movement-related symptoms such as slowness, stiffness, and tremor.

For many people, this is where treatment begins. Supporting Dopamine often brings noticeable improvement in mobility, fluidity of movement, and daily function.

This group addresses many of the core movement changes associated with PD.

Symptom-Targeted Medications

Symptom-targeted medications are used to address specific challenges that may not respond fully to Dopamine-based therapy alone. Some PD symptoms are not driven directly by Dopamine loss. Even when Dopamine is well supported, certain symptoms may persist or evolve over time.

These may include motor symptoms, such as uncontrolled movements (Dyskinesia) that can develop as a complication of long-term Dopamine therapy, or persistent tremor. They may also address non-motor symptoms such as sleep disturbances, mood changes, anxiety, blood pressure fluctuations, or other autonomic issues.

While symptom-targeted treatments do not primarily work by increasing Dopamine levels, they can significantly improve day-to-day functioning, comfort, and stability. Sometimes these adjustments make a meaningful difference in how manageable the day feels.

How It Comes Together

Most people living with PD use a combination of both approaches. Treatment plans often evolve over time, with medications adjusted based on symptom patterns, treatment response, side effects, and stage of disease.

This is not a sign that treatment has failed. It reflects the reality that PD changes over time, and care adapts along with it.

Text

Call

Burger

Taco

Netflix

Hulu

Coffee

Tea

Winter

Summer

Dog

Cat

We have been a speaker at 3 events before we decided to start our podcast!

three.

We've traveled to all the continents and the north still holds our hearts.

two.

Our pup Murphy is liiiiiife! He may even make an appearance on the pod!

one.

Fun Details

Why Dopamine Cannot Be Given Directly


Parkinson’s is associated with low Dopamine levels in specific areas of the brain.  A reasonable question follows: why not simply give Dopamine by pill or injection and restore what is missing?
Dopamine itself cannot cross the brain’s protective filter, called the Blood-Brain Barrier.

The Blood Brain Barrier is made of tightly packed cells lining the brain’s blood vessels. Its role is to protect the brain from toxins, infections, and harmful substances. As a result, it also blocks many medications, including Dopamine.

If Dopamine is taken by mouth or given by injection, it does not meaningfully enter the brain. Instead, it remains in the bloodstream.  Dopamine outside the brain can cause unwanted effects, including:
  • Nausea and vomiting
  • Blood pressure swings
  • Heart rhythm disturbances

Giving Dopamine directly would mostly produce side effects without improving Parkinson’s symptoms.


The Workaround: Levodopa and Carbidopa


Doctors use a strategic workaround.
They prescribe Levodopa, a Dopamine precursor. A precursor is a substance the brain can convert into Dopamine once it is inside.

Levodopa can cross the Blood Brain Barrier. Once inside the brain, it is converted into Dopamine where it is needed.
Levodopa works best when paired with Carbidopa.

Carbidopa:
  • Prevents Levodopa from converting into Dopamine too early, before it reaches the brain
  • Allows more Levodopa to reach the brain intact
  • Reduces side effects such as nausea and lightheadedness

Together, Levodopa and Carbidopa form the foundation of Parkinson’s medication treatment.  Levodopa and Carbidopa are the peanut butter and jelly of the Parkinson’s world.

Individually helpful. Together, they simply work better.
This combination remains the most effective medication for improving Parkinson’s movement symptoms.


From Ingredient to Action: Understanding Precursors


As noted, a precursor is something the body can turn into something else.  Think of it as the raw materials, not the finished product.

  • Dopamine is the fully assembled bookshelf.
  • Levodopa is the flat-packed box with a lot of parts, a tiny Allen wrench, and instructions made entirely of pictures.

The brain won’t accept a fully assembled bookshelf; it simply won’t get through the door. But it will accept the flat-packed box.

Levodopa can cross the Blood–Brain Barrier. Once it’s inside the brain, brain cells assemble it into Dopamine, right where it’s needed.

Bottom line:
The brain doesn’t want pre-assembled furniture.
It wants the box, the parts, and to quietly put it together itself, hopefully without losing the Allen wrench.


Different Formulations of Carbidopa/Levodpa


Carbidopa/Levodopa is often the first medication prescribed for Parkinson’s.

  • The original brand name many people recognize is Sinemet®. 
  •  The generic version is simply labeled Carbidopa/Levodopa.

Carbidopa/Levodopa comes in several different formulations, designed to release medication at different speeds:
• Immediate-Release Tablets (typically taken multiple times per day.)
• Controlled-Release (CR) Tablets (releases meds more slowly over time).
• Orally Disintegrating Tablets (ODT) 
 (Dissolve in the mouth-helpful for individuals with swallowing difficulty)
Extended-Release
(Designed to release meds gradually over time, instead of all at once.)









What Parkinson’s Medications Actually Target

Disease-targeting treatments focus on replacing dopamine, mimicking its effects, or helping existing dopamine last longer in the brain. These medications form the foundation of Parkinson’s treatment and are most effective for movement-related symptoms such as slowness, stiffness, and tremor.

Symptom-targeted treatments are used to address specific challenges that may not respond fully to dopamine-based therapy alone. These can include motor symptoms (such as dyskinesia or tremor) as well as non-motor symptoms (such as sleep problems, mood changes, or autonomic issues). While these treatments don’t directly change dopamine levels, they can significantly improve day-to-day functioning and comfort.

Most people with Parkinson’s use a combination of both approaches, and treatment plans often evolve over time. Medications are adjusted based on symptoms, response, side effects, and stage of disease, with the shared goal of maintaining the best possible quality of life.

Meds That Support Dopamine Beyond Replacement

Next layer of Dopamine Therapies

We’ve covered Dopamine replacement therapy (Carbidopa/Levodopa):  the foundation. The workhorse. The peanut butter and jelly of Parkinson’s medications.

This is the treatment that replaces the Dopamine the brain isn’t making enough of.

For many people, it works remarkably well, especially at first.

But Parkinson’s treatment is rarely a “one-pill and done” situation.

Over time, doses may wear off sooner. A morning that feels smooth can turn into an afternoon that feels unpredictable. That doesn’t mean the medication failed.

It means the brain is not a light switch. It’s more like a dimmer system with complicated wiring.

This is where the other medication categories come in.

These medications don’t just dump more Dopamine into the system. They fine-tune it.

  • Some help Dopamine stick around longer.
  • Some protect it from being cleared away too quickly.
  • Some step in and act like Dopamine when levels dip.
  • Others help smooth the transition between doses so you’re not riding a roller coaster every few hours.

Parkinson’s care isn’t just about adding more of something.  It’s about helping the brain’s movement network run more smoothly.

Less spike.
Less drop.
More steady, controlled movement.

Because steadiness is what makes a day feel livable.

Understanding these layers makes the treatment plan feel less mysterious, and more intentional.

What Parkinson’s Medications Actually Target

Disease-targeting treatments focus on replacing dopamine, mimicking its effects, or helping existing dopamine last longer in the brain. These medications form the foundation of Parkinson’s treatment and are most effective for movement-related symptoms such as slowness, stiffness, and tremor.

Symptom-targeted treatments are used to address specific challenges that may not respond fully to dopamine-based therapy alone. These can include motor symptoms (such as dyskinesia or tremor) as well as non-motor symptoms (such as sleep problems, mood changes, or autonomic issues). While these treatments don’t directly change dopamine levels, they can significantly improve day-to-day functioning and comfort.

Most people with Parkinson’s use a combination of both approaches, and treatment plans often evolve over time. Medications are adjusted based on symptoms, response, side effects, and stage of disease, with the shared goal of maintaining the best possible quality of life.

Meds That Support Dopamine Beyond Replacement

MAO-B Inhibitors

Examples: Rasagiline, Elegiline, Safinamide

What they do:

These medications slow the breakdown of Dopamine in the brain.

Normally, an enzyme called MAO-B breaks Dopamine down after it is used.  MAO-B inhibitors reduce that breakdown, allowing Dopamine to last longer.

When they’re used:
• Early in the disease for mild symptom support
• Added to Levodopa to help reduce “wearing off”

Think of them as:

A preservation system.  They don’t add more Dopamine, they help protect what’s already there..


Dopamine Protectors

COMT Inhibitors

Examples: Entacapone, Opicapone

What they do:
These medications slow the breakdown of Levodopa in the body before it reaches the brain.

This allows more Levodopa to enter the brain and extend how long each dose works.

When they’re used:

• When Levodopa starts wearing off between doses
• When symptom control becomes less consistent

Think of them as:

Helping each Levodopa dose travel farther and last longer.

They do not work independently.
They are always used alongside Levodopa.

Levodopa Extenders

Dopamine Agonists

Examples:
Pramipexole, Ropinirole, Rotigotine

What they do:
These medications directly stimulate Dopamine receptors in the brain.

They do not turn into Dopamine.
They act like Dopamine.

When they’re used:

• Sometimes early in treatment
• As add-on therapy
• Occasionally in younger patients to delay higher Levodopa doses

Important considerations:
They can be effective, but they carry a higher risk of side effects such as sleepiness, swelling, hallucinations, and impulse control behaviors.

Think of them as:
Artificial keys that fit into Dopamine locks.

Dopamine Mimics



Adenosine A2A Antagonists

Example: Istradefylline

What they do:
These medications work on a different brain pathway (adenosine receptors) that influences movement circuits.

They help smooth motor fluctuations and reduce “off” periods.

They do not increase Dopamine.
They help the brain respond more consistently when Dopamine levels fluctuate.

Think of them as:

Fine-tuning the circuitry rather than changing the fuel.

Signal Modifiers

What Parkinson’s Medications Actually Target

Disease-targeting treatments focus on replacing dopamine, mimicking its effects, or helping existing dopamine last longer in the brain. These medications form the foundation of Parkinson’s treatment and are most effective for movement-related symptoms such as slowness, stiffness, and tremor.

Symptom-targeted treatments are used to address specific challenges that may not respond fully to dopamine-based therapy alone. These can include motor symptoms (such as dyskinesia or tremor) as well as non-motor symptoms (such as sleep problems, mood changes, or autonomic issues). While these treatments don’t directly change dopamine levels, they can significantly improve day-to-day functioning and comfort.

Most people with Parkinson’s use a combination of both approaches, and treatment plans often evolve over time. Medications are adjusted based on symptoms, response, side effects, and stage of disease, with the shared goal of maintaining the best possible quality of life.

Levodopa and other Dopamine-based therapies have a limited duration in the body. When doses are delayed, missed, or taken at very different times each day, Dopamine levels can drop more abruptly. This may lead to increased stiffness, slower movement, tremor, or a return of “off” symptoms.

Because these medications are designed to maintain more stable brain Dopamine activity, timing plays an important role in how smooth the response feels.

This does not mean perfection is required. It means consistency matters.

Using reminders, alarms, or simple routines can help maintain steadier symptom control. 

Parkinson’s medications work best when taken on time and consistently.







Why Taking Your PD Meds On Time Matters

Adjusting doses on your own, skipping medication on “good” days, or doubling up after a missed dose can create more instability. These medications are designed to work as part of a steady plan, not in reaction to moment-to-moment changes.

If symptoms shift, wear off sooner, or new side effects appear, that is important information to share with your neurologist or primary care provider. Small, thoughtful adjustments are often more effective than sudden changes.

It is also helpful to keep an updated medication list and review it regularly with your care team. Parkinson’s treatment evolves over time.

This does not mean the plan is failing. It means it is being refined.




Parkinson’s medications work best when taken consistently and as prescribed.







Medication Works Best with Steady Habits

Amino acids are components your body uses to build proteins. Dopamine itself is made from one of these Amino Acids.

Because Levodopa and dietary protein use similar transport systems, eating a high protein meal at the same time as medication may reduce how much Levodopa reaches the brain.  This does not mean you should eliminate protein. It means timing can matter.  Some people are advised to take Levodopa away from large protein heavy meals to improve consistency. This is a practical adjustment, not a restriction.

Levodopa competes with certain amino acids, the building blocks of protein, to enter the brain. 

Protein, Timing, and Your Medication Plan

As the brain changes, though, its ability to store and manage Dopamine becomes less reliable. Medication may still work, just not as evenly as it once did.

You might notice:
• Medication “wearing off” before the next dose
• Shifts between feeling “on” and “off”
• Days that feel less consistent than they used to
• Extra/involuntary movement called Dyskinesia (more on this topic in next slide)

This does not mean your meds has failed.
It means Parkinson’s has changed, and your treatment plan may need to change with it.
Doctors often adjust timing, dosing, or add supportive therapies to smooth things out again.

In the early years, meds often feel smooth and predictable. You take a dose, it kicks in, and things feel steadier.







How Medications Change Over Time

Symptom-targeted treatments are often used to address challenges that may continue even when Dopamine levels are supported.

These treatments may help manage symptoms such as:

• Dyskinesia (involuntary movements that can develop after long-term Levodopa therapy)
• Sleep disturbances
• Mood changes, including depression or anxiety
• Autonomic symptoms, such as blood pressure fluctuations or dizziness

These medications do not primarily work by increasing Dopamine levels. Instead, they are designed to improve comfort, stability, and day-to-day functioning by addressing specific symptoms.

For many people living with Parkinson’s, treatment involves a combination of Dopamine-Targeting therapies and Symptom-Targeted approaches, working together to support overall symptom management.

Some Parkinson’s symptoms are not driven directly by Dopamine loss, which is why additional treatments may be needed.







Some Parkinson’s Symptoms Do Not Fully Respond to Dopamine Therapies

Some symptoms are driven by changes in:

• Sleep regulation centers
• Emotional processing networks
• Autonomic nervous system control
• Sensory processing pathways

That’s why treating Parkinson’s often requires more than Dopamine support alone.

Symptom-targeted therapies focus on specific systems that need stabilization — even when movement is well controlled.

This is not “extra medication.”
It’s system-level care.

Parkinson’s changes how multiple body systems communicate, not just the movement circuits.







PD Affects More Than Movement